Dexcom (DXCM) FCF Margin (2010 - 2026)
Dexcom (DXCM) posted quarterly FCF Margin of 14.1% for Q2 2026, down 395.0% year-over-year from 4.78% in Q2 2025, and down 62.57% quarter-over-quarter from 37.67% in Q1 2026.
Dexcom (DXCM) FCF Margin (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported FCF Margin for 17 consecutive years, with 14.1% the latest figure, recorded in Q2 2026.
- In Q2 2026, FCF Margin fell 395.0% year-over-year to 14.1%; the TTM figure through Jun 2026 stood at 28.27% (up 1500.0% YoY), while the FY2025 annual figure was 23.11%, up 747.0% from the prior year.
- FCF Margin eased to 14.1% in Q2 2026 per DXCM's latest filing, from 37.67% in the prior quarter.
- Across five years, FCF Margin topped out at 47.91% in Q3 2025 and bottomed at 4.87% in Q1 2022.
- Historically, FCF Margin has averaged 16.69% across 5 years, with a median of 15.16% in 2023.
- Annual changes were most pronounced in 2024 — FCF Margin sank 1356 bps — and 2025, when it soared 3903 bps.
- Dexcom's FCF Margin stood at 8.46% in 2022, then slipped by 7 bps to 7.84% in 2023, then surged by 103 bps to 15.88% in 2024, then fell by 4 bps to 15.25% in 2025, then retreated by 8 bps to 14.1% in 2026.
- Business Quant data shows DXCM's FCF Margin at 14.1% in Q2 2026, 37.67% in Q1 2026, and 15.25% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 18.73% |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn | 18.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.10% |
| Mar 31, 2026 | 37.67% |
| Dec 31, 2025 | 15.25% |
| Sep 30, 2025 | 47.91% |
| Jun 30, 2025 | 18.05% |
| Mar 31, 2025 | 9.34% |
| Dec 31, 2024 | 15.88% |
| Sep 30, 2024 | 8.88% |
| Jun 30, 2024 | 21.24% |
| Mar 31, 2024 | 16.54% |
| Dec 31, 2023 | 7.84% |
| Sep 30, 2023 | 22.44% |
| Jun 30, 2023 | 15.07% |
| Mar 31, 2023 | 10.88% |
| Dec 31, 2022 | 8.46% |
| Sep 30, 2022 | 24.04% |
| Jun 30, 2022 | 11.68% |
| Mar 31, 2022 | -4.87% |
| Dec 31, 2021 | 3.67% |
| Sep 30, 2021 | 21.41% |